Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Cardiovascular Events in Multiple Myeloma: A Retrospective Review of the SEER-Medicare Claims Database

Victoria A. Vardell, Joshua J. Horns, Anees A Daud, Douglas W Sborov

Blood (2024) 144 (Supplement 1): 6942.

https://doi.org/10.1182/blood-2024-210695

Published: 2024

Journal Articles

Real-World Comparison of BCL2 Inhibitor and BTK Inhibitor Therapy in the Front-Line Treatment of CLL Including Patients with Del(17p)/TP53 Mutation

Daniel A. Ermann, Victoria A. Vardell, Allison M. Bock, Joshua J. Horns, Harsh R. Shah, Lindsey Fitzgerald, Boyu Hu, Adam S Kittai, Deborah M. Stephens

Blood (2024) 144 (Supplement 1): 1864.

https://doi.org/10.1182/blood-2024-204134

Published: 2024

Journal Articles

Mixed Phenotype Acute Leukemias: Real-World Outcomes By Who Classifications 2010-2021

Victoria A. Vardell, Srinivas K Tantravahi

Blood (2024) 144 (Supplement 1): 2420.

https://doi.org/10.1182/blood-2024-211497

Published: 2024

Journal Articles

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Real-World Outcomes and Disparities in the Era of Novel Therapies, 2010-2021

Victoria A. Vardell, Srinivas K Tantravahi

Blood (2024) 144 (Supplement 1): 2334.

https://doi.org/10.1182/blood-2024-210983

Published: 2024

Journal Articles

High Rates of Thrombotic Events in Newly Diagnosed Multiple Myeloma Patients Enrolled on the Maia Trial

Sterling Rosqvist, Victoria A. Vardell, Eric Anto, Gliceida Galarza Fortuna, Douglas Peters, Charlotte B Wagner, Baylee Bryan, Mary Nicole Steinbach, Samuel Shewan, Lindsay Maxwell, Michael R. Savona, Kelley Julian, Brian McClune, Ghulam Rehman Mohyuddin, Amandeep Godara, Muhamed Baljevic, Douglas Sborov

Blood (2023) 142 (Supplement 1): 4718.

https://doi.org/10.1182/blood-2023-190746

Published: 2023

Journal Articles

Trends in Survival Outcomes for Mantle Cell Lymphoma in the Era of Novel Therapies

Daniel A. Ermann, Victoria A. Vardell, Lindsey Fitzgerald, Harsh Shah, Allison M. Bock, Deborah M. Stephens, Boyu Hu

Blood (2023) 142 (Supplement 1): 1669.

https://doi.org/10.1182/blood-2023-190383

Published: 2023

Journal Articles

Real World Outcomes of Black Americans with Mantle Cell Lymphoma

Victoria A. Vardell, Boyu Hu, Lindsey Fitzgerald, Harsh Shah, Allison M. Bock, Deborah M. Stephens, Daniel A. Ermann

Blood (2023) 142 (Supplement 1): 4412.

https://doi.org/10.1182/blood-2023-190719

Published: 2023

Journal Articles

Relapsed and Refractory Multiple Myeloma with Pleural Involvement: A Case Series

Douglas Peters, Victoria A. Vardell, Gliceida Galarza Fortuna, Sterling Rosqvist, Charlotte B Wagner, Kelley Julian, Baylee Bryan, Mary Nicole Steinbach, Samuel Shewan, Lindsay Maxwell, Brian McClune, Amandeep Godara, Ghulam Rehman Mohyuddin, Matthew F Covington, Douglas Sborov

Blood (2023) 142 (Supplement 1): 6630.

https://doi.org/10.1182/blood-2023-179287

Published: 2023

Journal Articles

Survival Outcomes of Rural Patients with Mantle Cell Lymphoma

Zach Rubnitz, Victoria A. Vardell, Lindsey Fitzgerald, Allison M. Bock, Harsh Shah, Boyu Hu, Deborah M. Stephens, Daniel A. Ermann

Blood (2023) 142 (Supplement 1): 6169.

https://doi.org/10.1182/blood-2023-189285

Published: 2023

Journal Articles

Trends in Frontline Treatment and Overall Survival in the Era of Targeted Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia

Victoria A. Vardell, Catherine E. Sobieski, Srinivas K. Tantravahi

Blood (2022) 140 (Supplement 1): 6763–6764.

https://doi.org/10.1182/blood-2022-167855

Published: 2022

Journal Articles

Treatment and Overall Survival Outcomes of Patients with B-Cell Prolymphocytic Leukemia

Daniel A. Ermann, Victoria A. Vardell, Lindsey A. Fitzgerald, Harsh Shah, Boyu Hu, Deborah M. Stephens

Blood (2022) 140 (Supplement 1): 6668–6669.

https://doi.org/10.1182/blood-2022-170666

Published: 2022

Journal Articles

Racial and Ethnic Disparities in Survival Outcomes in Chronic Myeloid Leukemia

Catherine E. Sobieski, Victoria A. Vardell, Srinivas K. Tantravahi

Blood (2022) 140 (Supplement 1): 1507–1508.

https://doi.org/10.1182/blood-2022-167889

Published: 2022

Journal Articles

T-Cell Prolymphocytic Leukemia: Trends in Overall Survival Demonstrate Marginal Improvement over Time and Minimal Benefit with Currently Available Treatments

Victoria A. Vardell, Daniel A. Ermann, Harsh Shah, Lindsey A. Fitzgerald, Boyu Hu, Deborah M. Stephens

Blood (2022) 140 (Supplement 1): 1085–1086.

https://doi.org/10.1182/blood-2022-169918

Published: 2022

Journal Articles

Survival Disparities Among People with HIV and Diffuse Large B-Cell Lymphoma in the Era of Novel Antiretroviral Therapy

Daniel A. Ermann, Victoria A. Vardell, Manasa Velagapudi, Greer Burkholder, Lindsey A. Fitzgerald, Mayur Narkhede, Harsh Shah, Lauren Shea, Adam Spivak, Deborah M. Stephens, Boyu Hu, Gaurav Goyal

Blood (2022) 140 (Supplement 1): 1076–1078.

https://doi.org/10.1182/blood-2022-169930

Published: 2022

Journal Articles

Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A National Analysis of Overall Survival and Demographic Features

Victoria A. Vardell, Douglas J. Peters, Srinivas K. Tantravahi, Ami B. Patel

Blood (2022) 140 (Supplement 1): 1350–1352.

https://doi.org/10.1182/blood-2022-170734

Published: 2022

Journal Articles

Plasma Cell Leukemia: A Multicenter Retrospective Study of 130 Patients

Iloabueke Chineke, Betsy Wertheim, Denise Roe, Ashley Larsen, Victoria A. Vardell, Douglas W. Sborov, Damian J. Green, Michaela Liedtke, Marie Okoniewski, Mohammed Wazir, Omar Nadeem, Levanto Schachter, David Coffey, Krisstina L. Gowin, Dominique DeGraaff

Blood (2022) 140 (Supplement 1): 7144–7146.

https://doi.org/10.1182/blood-2022-164713

Published: 2022

Journal Articles

Multiple Myeloma Patients Treated at Academic Centers Have Improved Survival Outcomes

Victoria A. Vardell, Daniel A. Ermann, Srinivas K. Tantravahi, Brian McClune, Mary Nicole Steinbach, Ghulam Rehman Mohyuddin, Amandeep Godara, Douglas W. Sborov

Blood (2021) 138 (Supplement 1): 1971.

https://doi.org/10.1182/blood-2021-151899

Published: 2021

Journal Articles

Treatment Outcomes of Consolidative Radiation in Extranodal Early-Stage Diffuse Large B-Cell Lymphoma

Daniel A. Ermann, Victoria A. Vardell, Harsh Shah, Randa Tao, David K. Gaffney, Deborah M. Stephens, Boyu Hu

Blood (2021) 138 (Supplement 1): 49.

https://doi.org/10.1182/blood-2021-153197

Published: 2021

Journal Articles

Angioimmunoblastic T-Cell Lymphoma: Patient Characteristics and Survival Outcomes

Daniel A. Ermann, MD, Victoria A. Vardell, MD, Peter T. Silberstein, MD

Blood (2019) 134 (Supplement_1): 2194.

https://doi.org/10.1182/blood-2019-132077

Published: 2019

Journal Articles

Racial and Socioeconomic Disparities in the Utilization of Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in the Era of Novel Agents

Victoria A. Vardell, MD, Daniel Ermann, MD, Maryam Gbadamosi-Akindele, MD, Funmi Badejo, Peter T. Silberstein, MD, Srinivas K. Tantravahi, MBBS

Blood (2019) 134 (Supplement_1): 423.

https://doi.org/10.1182/blood-2019-130859

Published: 2019

NARROW

Cardiovascular Events in Multiple Myeloma: A Retrospective Review of the SEER-Medicare Claims Database

Real-World Comparison of BCL2 Inhibitor and BTK Inhibitor Therapy in the Front-Line Treatment of CLL Including Patients with Del(17p)/TP53 Mutation

Mixed Phenotype Acute Leukemias: Real-World Outcomes By Who Classifications 2010-2021

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Real-World Outcomes and Disparities in the Era of Novel Therapies, 2010-2021

High Rates of Thrombotic Events in Newly Diagnosed Multiple Myeloma Patients Enrolled on the Maia Trial

Trends in Survival Outcomes for Mantle Cell Lymphoma in the Era of Novel Therapies

Real World Outcomes of Black Americans with Mantle Cell Lymphoma

Relapsed and Refractory Multiple Myeloma with Pleural Involvement: A Case Series

Survival Outcomes of Rural Patients with Mantle Cell Lymphoma

Trends in Frontline Treatment and Overall Survival in the Era of Targeted Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia

Treatment and Overall Survival Outcomes of Patients with B-Cell Prolymphocytic Leukemia

Racial and Ethnic Disparities in Survival Outcomes in Chronic Myeloid Leukemia

T-Cell Prolymphocytic Leukemia: Trends in Overall Survival Demonstrate Marginal Improvement over Time and Minimal Benefit with Currently Available Treatments

Survival Disparities Among People with HIV and Diffuse Large B-Cell Lymphoma in the Era of Novel Antiretroviral Therapy

Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A National Analysis of Overall Survival and Demographic Features

Plasma Cell Leukemia: A Multicenter Retrospective Study of 130 Patients

Multiple Myeloma Patients Treated at Academic Centers Have Improved Survival Outcomes

Treatment Outcomes of Consolidative Radiation in Extranodal Early-Stage Diffuse Large B-Cell Lymphoma

Angioimmunoblastic T-Cell Lymphoma: Patient Characteristics and Survival Outcomes

Racial and Socioeconomic Disparities in the Utilization of Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in the Era of Novel Agents

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only